InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by PAKOLA STEVE, Directeur Médical. Officer active across 1 companies, notably REGENXBIO Inc.. In total, 2 reports have been recorded. The latest transaction was filed on 1 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€33,2631,152 shares@ €28.8741100.0% of flow
Common Stock
SEC:0001562180-22-000159·
€33,2631,152 shares@ €28.87410.011% mcap50.0% of flow
Common Stock
SEC:0001562180-22-000159:0·
2 of 2 declarations
About PAKOLA STEVE
Steve Pakola is the Chief Medical Officer at Regenxbio Inc. He oversees the company's medical initiatives, including product development and clinical trials. With a strong medical background, he plays a key role in the strategic direction of research and development programs. His expertise contributes to innovation and improved patient outcomes.
